scPharmaceuticals Obtains $45,600,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b84ca97-8e6a-44ff-b6d0-0b3d848a35ae - Date
1/5/2017 - Company Name
scPharmaceuticals - Mailing Address
131 Hartwell Avenue Lexington, MA 02421 USA - Company Description
scPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration. - Website
http://www.scpharma.com - Transaction Type
Venture Equity - Transaction Amount
$45,600,000 - Transaction Round
Series B - Proceeds Purposes
This Series B investment will support the development of the operational and commercial infrastructure to bring Furoscix™ and the sc2Wear™ Infusor to market in the United States. - M&A Terms
- Venture Investor
OrbiMed - Venture Investor
5AM Ventures - Venture Investor
Lundbeckfond Ventures
